Sarepta Therapeutics (SRPT) Retained Earnings (2010 - 2026)
Sarepta Therapeutics' (SRPT) quarterly Retained Earnings came in at -$121000.0 in Q1 2026, down 455.88% year-on-year from $34000.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$4.9 billion in Q4 2025.
Sarepta Therapeutics (SRPT) Retained Earnings (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$121000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings fell 455.88% year-over-year to -$121000.0 in Q1 2026; TTM through Mar 2026 was -$121000.0, a 455.88% decrease from a year earlier, with the FY2025 full-year figure at -$4.9 billion, down 15.82% from the prior year.
- Retained Earnings improved to -$121000.0 in Q1 2026 per SRPT's latest filing, from -$4.9 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $918000.0 in Q4 2023 and bottomed at -$4.9 billion in Q4 2025.
- The 5-year median for Retained Earnings is -$2.5 million (2022), against an average of -$1.8 billion.
- Across the five-year window, Retained Earnings plunged 1446629.08% in 2023 and soared 104.92% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$3.9 billion in 2022, then soared by 100.02% to $918000.0 in 2023, then slumped by 458811.76% to -$4.2 billion in 2024, then declined by 15.82% to -$4.9 billion in 2025, then soared by 100.0% to -$121000.0 in 2026.
- Per Business Quant, the three latest SRPT Retained Earnings figures stand at -$121000.0 (Q1 2026), -$4.9 billion (Q4 2025), and $220000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn | -121,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121,000.00 |
| Dec 31, 2025 | -4.88 Bn |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | -4.21 Bn |
| Sep 30, 2024 | -4.37 Bn |
| Jun 30, 2024 | -4.40 Bn |
| Mar 31, 2024 | -691,000.00 |
| Dec 31, 2023 | 918,000.00 |
| Sep 30, 2023 | -4.49 Bn |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -4.43 Bn |
| Dec 31, 2022 | -3.91 Bn |
| Sep 30, 2022 | -3.21 Mn |
| Jun 30, 2022 | -2.49 Mn |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | -3.21 Bn |
| Sep 30, 2021 | -3.08 Bn |
| Jun 30, 2021 | -3.04 Bn |